Earnings Feed
Start Free
Home/Filings/4/0001855763-22-000014
4//SEC Filing

BUNKA CHRISTOPHER 4

Accession 0001855763-22-000014

CIK 0001348362other
View on SEC.govCompany Profile

Filed

Oct 12, 8:00 PM ET

Accepted

Oct 13, 5:00 PM ET

Size

13.7 KB

Accession

0001855763-22-000014

Insider Transaction Report

Form 4
Period: 2022-10-12
Lexaria Bioscience Corp.LEXX
BUNKA CHRISTOPHER
DirectorChariman/CEO/President/CFO
Transactions
  • Award

    common shares

    2022-10-12$1.99/sh+21,900$43,537→ 237,812 total(indirect: Private Holding Company)
  • Award

    common shares

    2022-10-13$2.10/sh+16,600$34,860→ 254,412 total(indirect: Private Holding Company)
Holdings

  • common shares

    273,543

  • common shares

    (indirect: Private Holding Company)
    215,912

  • Stock Options

    Exercise: $2.91From: 2022-08-29Exp: 2027-08-29→ Common Shares (30,000 underlying)
    101,001

  • Warrants

    (indirect: Private Holding Company)
    Exercise: $10.50From: 2020-05-06Exp: 2025-05-06→ Common Shares (6,667 underlying)
    6,667

  • Stock Options

    Exercise: $5.83From: 2021-04-26Exp: 2026-04-26→ Common Shares (26,000 underlying)
    32,667

  • Stock Options

    Exercise: $7.08From: 2021-06-08Exp: 2026-06-08→ Common Shares (23,334 underlying)
    56,001

  • Stock Options

    Exercise: $6.23From: 2021-09-01Exp: 2026-09-01→ Common Shares (15,000 underlying)
    71,001

Documents

1 file

Issuer

Lexaria Bioscience Corp.

CIK 0001348362

→
Entity typeother

Related Parties

1
  • filerCIK 0001103780

Filing Metadata

Form type
4
Filed
Oct 12, 8:00 PM ET
Accepted
Oct 13, 5:00 PM ET
Size
13.7 KB
View on SEC.gov